本页面由Tiger Trade Technology Pte. Ltd.提供服务

Maravai LifeSciences Holdings, Inc.

3.43
-0.0900-2.56%
盘后3.33-0.1010-2.94%19:15 EST
成交量:122.82万
成交额:424.30万
市值:8.77亿
市盈率:-4.07
高:3.56
开:3.49
低:3.40
收:3.52
52周最高:6.21
52周最低:1.67
股本:2.56亿
流通股本:9,274.95万
量比:0.95
换手率:1.32%
股息:- -
股息率:- -
每股收益(TTM):-0.8429
每股收益(LYR):-1.0503
净资产收益率:-40.92%
总资产收益率:-7.78%
市净率:3.57
市盈率(LYR):-3.27

数据加载中...

2021/05/20

重要事件披露

8-K - Current report
2021/05/12

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/05/10

重要事件披露

8-K - Current report
2021/04/12

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/04/06

[修订]招股说明书

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2021/04/05

SEC问询函

CORRESP [Cover] - Correspondence
2021/04/05

SEC问询函

CORRESP [Cover] - Correspondence
2021/04/05

重要事件披露

8-K - Current report
2021/04/05

招股说明书

S-1 - General form for registration of securities under the Securities Act of 1933
2021/03/22

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2021/03/02

重要事件披露

8-K - Current report
2021/02/16

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/11

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/10

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/08

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/11/25

重要事件披露

8-K - Current report
2020/11/23

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2020/11/16

SEC问询函

CORRESP [Cover] - Correspondence
2020/11/16

SEC问询函

CORRESP [Cover] - Correspondence
2020/11/13

[修订]招股说明书

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933